Go Deep
Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 21,890 | 30.5 | 2.63 | 0.19 | 1,211.00 |
| Sep 2026 | 21,902 | 30.4 | 2.63 | 0.19 | 1,209.10 |
| Sep 2026 | 21,330 | 30.7 | 2.65 | 0.19 | 1,221.00 |
| Sep 2026 | 21,330 | 30.7 | 2.65 | 0.19 | 1,221.00 |
| Sep 2026 | 21,330 | 30.7 | 2.65 | 0.19 | 1,221.00 |
| Sep 2026 | 21,331 | 30.2 | 2.65 | 0.19 | 1,221.00 |
| Oct 2026 | 21,097 | 30.4 | 2.62 | 0.19 | 1,206.20 |
| Oct 2026 | 20,626 | 30.1 | 2.60 | 0.19 | 1,197.00 |
Dr. Reddy's Laboratories Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 80,705,000,000.0 | 75,162,000,000.0 | 87,268,000,000.0 | 88,051,000,000.0 |
| Net Profit | 4,435,000,000.0 | 2,209,000,000.0 | 12,098,000,000.0 | 14,372,000,000.0 |
| EPS | 5.3 | 2.6 | 14.5 | — |
Dr. Reddy's Laboratories Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 335,933,000,000.0 | 325,535,000,000.0 | 279,164,000,000.0 | 245,879,000,000.0 | — |
| Net Profit | 42,850,000,000.0 | 56,544,000,000.0 | 55,684,000,000.0 | 45,067,000,000.0 | — |
| EPS | 51.5 | 67.9 | 67.0 | 54.3 | — |
Dr. Reddy's Laboratories Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 579,346,000,000.0 | 492,989,000,000.0 | 387,518,000,000.0 | 321,854,000,000.0 | — |
| Total Liabilities | 198,889,000,000.0 | 155,823,000,000.0 | 106,968,000,000.0 | 90,863,000,000.0 | — |
| Total Equity | 377,063,000,000.0 | 333,388,000,000.0 | 280,550,000,000.0 | 230,991,000,000.0 | — |
Owes vs Owns
Dr. Reddy's Laboratories Limited owed ₹0.33 for every ₹1 it owned in Jun 2026, up from ₹0.28 in Mar 2023.
| Period | Jun 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.33× | 0.34× | 0.32× | 0.28× | 0.28× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Dr. Reddy's Laboratories Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 15.2%Receivables 21.3%Inventory 13.2%Fixed assets (tangible) 20.0%Intangible assets 20.4%Long-term investments 2.8%Other assets 7.2%
How it's funded — Mar 2026
Short-term debt 10.9%Long-term debt 2.1%Payables 3.9%Other liabilities 17.5%Shareholders' equity 65.7%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 8,781.4 | 5,790.8 | 8,147.0 | 6,179.7 |
| Receivables | 12,317.2 | 10,979.2 | 9,533.8 | 8,320.3 |
| Inventory | 7,653.1 | 7,108.5 | 6,355.2 | 4,867.0 |
| Fixed assets (tangible) | 11,593.0 | 9,776.1 | 7,688.6 | 6,646.2 |
| Intangible assets | 11,795.2 | 10,861.3 | 4,120.4 | 3,509.4 |
| Long-term investments | 1,636.8 | 1,520.2 | 525.5 | 536.2 |
| Other assets | 4,157.9 | 3,262.8 | 2,381.3 | 2,126.6 |
| Liabilities & equity | ||||
| Short-term debt | 6,293.4 | 3,804.5 | 1,272.3 | 1,119.0 |
| Long-term debt | 1,220.3 | 380.0 | 380.0 | 127.8 |
| Payables | 2,236.2 | 2,005.3 | 2,154.7 | 1,785.7 |
| Other liabilities | 10,139.0 | 9,392.5 | 6,889.8 | 6,053.8 |
| Shareholders' equity | 38,045.7 | 33,716.6 | 28,055.0 | 23,099.1 |
| Net tangible assets | 25,911.1 | 22,477.5 | 23,934.6 | 19,589.7 |
Dr. Reddy's Laboratories Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 56,755,000,000.0 | 46,428,000,000.0 | 45,433,000,000.0 | 58,875,000,000.0 | — |
| Investing Activities | -65,513,000,000.0 | -58,077,000,000.0 | -40,283,000,000.0 | -41,373,000,000.0 | — |
| Financing Activities | 8,290,000,000.0 | 18,911,000,000.0 | -3,763,000,000.0 | -26,861,000,000.0 | — |